Schneiderman Prelims Vol-I. qxd

HYPERPIGMENTED LESIONS,
DISCRETE ANNULAR
AUTOIMMUNE DISEASES, AND DISEASES
OF IMMUNE DYSFUNCTION
Bullous pemphigoid – figurate lesions, resolved 
Rook
p.1869–1870, 1998, Sixth Edition
Dermatitis herpetiformis 
Rook p.1890, Sixth Edition
Linear IgA disease
Lupus erythematosus – discoid lupus erythematosus 
Rook
p.2444–2449, 1998, Sixth Edition; NEJM 269:1155–1161, 1963;
lupus profundus; neonatal LE 
JAAD 40:675–681, 1999; Clin Exp
Rheumatol 6:169–172, 1988; subacute cutaneous LE; bullous
dermatosis of SLE 
JAAD 27:389–394, 1992; Arthritis Rheum
21:58–61, 1978; subacute
Morphea 
Rook p.2504–2508, 1998, Sixth Edition
CONGENITAL
Pre-auricular skin defects 
AD 133:1551–1554, 1997
Congenital smooth muscle hamartoma 
Curr Prob Derm
14:41–70, 2002
Transient neonatal pustular melanosis 
Eichenfeld, 2001, p.93;
Int J Dermatol 18:636–638, 1979; J Pediatr 88:831–835, 1976
DRUG-INDUCED
AZT pigmentation
Antimalarial pigmentation (atabrine) 
Bleomycin
Chemotherapy – under adhesive bandages after chemotherapy –
linear, annular and diffuse hyperpigmentation 
Ped Derm
8:231–235, 1991
Clofazamine pigmentation within lesions of Hansen’s disease
Doxorubicin (liposomal) – melanotic macules
AD 136:1475–1480, 2000
Fixed drug eruptions
Gold – chrysiasis – periorbital hyperpigmentation 
Cutis
68:53–55, 2001
Insulin reactions – itchy nodule evolves into hyperpigmentation
Int J Derm 23:567–583, 1984
Minocycline hyperpigmentation
Polyethylene glycol-coated liposomal doxorubicin – melanotic
macules 
AD 136:1475–1480, 2000
Prostaglandin F
2
α
analog (latanoprost) eyedrops –
hyperpigmentation and trichomegaly (eyelash hypertrichosis)
JAAD 44:721–723, 2001; Cutis 67:109–110, 2001
Stem cell factors, injected
Tattoo pigment fanning – periorbital hyperpigmentation
Cutis 68:53–55, 2001
Vitamin K allergy